Therapeutic nanostructures and nanotoxicity
Authors:
- 28 February 2021
- journal article
- review article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 41 (10) , 1494-1517
Abstract
Nanotechnology, with its continuous advancement, leads to the development of nanoscale‐level therapeutics to mitigate many complex diseases. This results in the emergence of numerous novel nanomaterials and its composite products into the market such as liposome, polymeric nanoparticles, dendrimers, and nanostructured lipid carrier. However, their application is always determined by a high benefit to risk ratio. Very few research have been done on the toxicity assessment of nanoparticles in the biological system; therefore, the limited knowledge regarding the toxicity profile of nanotherapeutics is available leading to the ignorance of its side effects. Nanoparticles can distribute in the whole body through translocating in the bloodstream by crossing membrane barriers efficiently and shows effect in organs and tissues at cellular and molecular levels. The interaction of nanoparticle with cell may consequences into nanotoxicity. The narrow size distribution, large surface area to mass ratio and surface properties of nanoparticle are significantly associated with nanotoxicity. Nanoparticles can enter into the tissue and cell by invading the membranes and cause cellular injury as well as toxicity. Therefore, the exploration of mechanisms of nanotoxicity has prime importance now a day. The toxicity assessment should be an integral part of the development of nanotherapeutics using various toxicity evaluation models. This review has focused on the exploration of different nanostructures for therapeutic delivery system along with its physicochemical characteristics responsible for adverse effects on human biology, various toxicity evaluation models, and environmental and regulatory hurdles.Keywords
This publication has 223 references indexed in Scilit:
- Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblastsToxicology Letters, 2013
- Toxicology and clinical potential of nanoparticlesNano Today, 2011
- Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issuesNanomedicine: Nanotechnology, Biology and Medicine, 2011
- A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cellsScience of The Total Environment, 2011
- Cadmium-containing nanoparticles: Perspectives on pharmacology and toxicology of quantum dots☆Toxicology and Applied Pharmacology, 2009
- Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivoJournal of Controlled Release, 2007
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Free radicals, metals and antioxidants in oxidative stress-induced cancerChemico-Biological Interactions, 2006
- Nanomedicine and nanotoxicology: two sides of the same coinNanomedicine: Nanotechnology, Biology and Medicine, 2005
- ROS stress in cancer cells and therapeutic implicationsDrug Resistance Updates, 2004